human glutathione synthetase structure Overview of de novo synthesis . Reduced glutathione or GSH The structure of the human
Description
The fundamental mechanism was characterized by an increased function of the xCT transporter, which resulted in the activation of metabotropic glutamate receptor 2 (mGluR2)

Batal M, Boudry I, Clry-Barraud C, Mouret S, Douki T

Affected individuals experience dystonia, gait abnormalities, and speech disturbances, along with distinct features such as polycythemia and liver disease (Zaki et al., 2018

consultation with a healthcare provider before combining these medications is medically necessary
